April 16, 2014


ASCO, ESMO, EORTC, ESO, and UICC Continue Endorsing the WIN Symposium Series in 2014

WIN 2014 Symposium

Five major cancer organizations which have endorsed previous events in the WIN Symposium Series, are also endorsing the WIN 2014 Symposium, to be held in Paris, June 23 - 24. The high scientific level and expected strong impact of this symposium are reflected by endorsements received from ASCO*, ESMO, EORTC, ESO, and UICC.


Continue Reading >

April 13, 2014


Real-World Patient Survey Data Shows Negative Impact of Nocturia

New patient survey data presented today at the European Association of Urology (EAU 14) congress, showed that nocturia (waking to void one or more times a night followed by sleep), has a strong negative impact on utility, work productivity and health-related quality of life (HRQL), which increases with the severity of the condition1,2.

An analysis of survey data drawn from"...

Continue Reading >

April 12, 2014


New Studies Show Health Risks from Wireless Tech: Warnings from the BioInitiative Working Group

The BioInitiative Working Group says evidence for health risk from wireless tech is growing stronger and warrants immediate action. The Group released a mid-year update covering new science studies from 2012 to 2014.

New studies intensify medical concerns about malignant brain tumors from cell phone use. “There is a consistent pattern of increased risk for glioma (a"...

Continue Reading >

April 12, 2014


Risk of Ebola virus outbreak in Algeria, low, says Health ministry

The risk of Ebola virus outbreak in Algeria is "low," said Thursday the Ministry of Health, Population and Hospital Reform in a statement.

"After analysing the situation, the special committee of experts in different areas, said that there is a low risk of Ebola outbreak in Algeria," said the Health ministry, which has however taken many preventive measures.


Continue Reading >

April 11, 2014


MoI: 5 Confirmed Cases of Coronavirus Infection, with One Dead

The Ministry of Interior has reported six cases of infection by the Middle East Respiratory Syndrome Coronavirus (Mers-CoV) among its Filipino paramedics working at the Al Ain Rescue and Ambulance Section, with one of them succumbing to the disease. The cases were diagnosed during the periodic medical examinations. In a statement issued in this regard, the ministry announced that it has taken all necessary preventive health measures by placing the patients under quarantine. “The ministry has also been in touch with community"...

Continue Reading >

April 9, 2014


Shiseido Focuses on Langerhans Cells to Strengthen Skin Immunity

Shiseido Co., Ltd. (TOKYO:4911) has long focused its research on skin immunity as an important means of maintaining skin’s health, and protecting it from external and internal stressors that can lead to dermatologic problems. Through this research, Shiseido discovered that one function of skin immunity, the self-protection function that sedates the stimuli response factors of Langerhans cells,1 is important to maintaining skin homeostasis and that this function declines with age.


Continue Reading >

April 8, 2014


Bioventus Releases New EXOGEN® and Performance Guarantee in Canada

Bioventus, a global leader in active orthopaedic healing, today announced that the next generation of its market-leading1 EXOGEN® Ultrasound Bone Healing System – including new compliance features and a healing progression Performance Guarantee – is now available in Canada.

EXOGEN® – the clinically proven treatment for indicated* bone fractures"...

Continue Reading >

April 8, 2014


CEO Roundtable on Cancer Launches the Project Data Sphere Initiative, A New Data Sharing and Analytic Platform for Cancer Patient Benefit

Project Data Sphere, LLC (PDS), an independent not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC), announced today the launch of a new data sharing platform (, with the goal of advancing research to improve the lives of cancer patients and their families around the world. The CEO Roundtable on Cancer was established in 2001 with the mandate to bring bold and imaginative solutions to cancer care.


Continue Reading >

April 8, 2014


FDA approves Pradaxa® for treatment and reduction in risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE)

  • New indications for Pradaxa® offer U.S. DVT and PE patients a simple treatment option that is as effective as warfarin with significantly less bleedings1,2,3
  • Almost one in three DVT or PE patients die within three months; DVT-related PE is the leading cause of preventable death in hospital4,5
  • FDA approval broadens use of Pradaxa® in the U.S.; Pradaxa® is already approved for stroke prevention in patients with atrial fibrillation6

For media outside of the U.S., the UK & Canada"...

Continue Reading >

April 8, 2014


Algeria sets up surveillance, warning system to prevent Ebola fever

Algeria has set up a surveillance and warning system for the prevention of Ebola fever, said Monday in Algiers, The director of prevention at the Ministry of Health, Population and Hospital Reform, Pr. Ismail Mesbah.

On the sidelines of a seminar marking the celebration of the World Health Day, observed every 7 April, Pr. Ismail Mesbah announced a meeting of a committee"...

Continue Reading >